EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

A multi-phase project to develop a patient-reported measure of barriers to antiretroviral therapy adherence for use in HIV care: The 7-Item I-Score

Kim Engler iD, David Lessard, Serge Vicente, Darrell H S Tan iD, Karine Lacombe, Bertrand Lebouché

PLOS One · 06.01.2026 · 21 (1) · e0324241

DOI: 10.1371/journal.pone.0324241 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift PLOS One, online erschienen am 06.01.2026. Verfasst von Kim Engler und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada. Hauptthemen laut MEDLINE: HIV Infections, Anti-HIV Agents, Medication Adherence, Patient Reported Outcome Measures. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian HIV Trials Network, Canadian Institutes of Health Research, Strategy for Patient-Oriented Research, Merck Canada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adherence to antiretroviral therapy (ART) is a priority in HIV care. Our goal was to develop and validate a new, short patient-reported outcome measure to screen for barriers to daily oral ART adherence in HIV care in Canada and France. The overarching design was that of a multi-phase, multi-site instrument development project. It involved a previously published qualitative research synthesis (to develop a conceptual framework from which to generate items). Here, we present the results of cognitive interviews (for content validity testing of the preliminary items) and of a longitudinal survey-based study where the revised 7-item instrument (the I-Score) was administered at two timepoints (baseline, 4 weeks), along with five indirect measures of ART adherence, including self-reported HIV viral load and, for a subset of Montreal participants, plasma viral load. The survey data was used to analyze the instrument’s measurement properties, namely structural validity (e.g., with Pearson inter-item correlations); construct validity, including cross-cultural validity, for a variety of sociodemographic groups (with receiver operating curve (ROC) analyses and areas under the curve (AUC); reliability (with the intraclass correlation coefficient (ICC)); and measurement error (with the standard error of measurement (SEM)). Study participants were adults living with HIV on antiretroviral therapy recruited from hospital-based infectious disease centers and community-based organizations in Montreal, Toronto, and Paris. The qualitative synthesis of 41 studies led to a framework composed of 6 barrier domains. One item was generated per domain. The 6-item measure was submitted to cognitive testing with 12 adults living with HIV, leading to several changes, including the division of one item into two, creating a 7-item measure. Overall, 305 adults living with HIV participated in the survey. Inter-item correlations were low to moderate, suggesting no redundant items. Among conclusive results, AUC’s were all above the predefined threshold (≥ 0.70) for self-reported viral load and plasma viral load for the global sample and across all subgroups examined. The ICC, at 0.81, was also above the predefined threshold (≥ 0.70). The SEM was 0.43. Overall, the evidence generated supports the 7-item I-Score measure’s content validity, construct validity/cross-cultural validity, reliability, and acceptable measurement error, in its specified context of use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsAnti-HIV AgentsMedication AdherencePatient Reported Outcome MeasuresHumansMaleFemaleAdultMiddle AgedViral LoadCanadaLongitudinal StudiesReproducibility of ResultsSelf ReportSurveys and QuestionnairesFrance

Substanzen

Anti-HIV Agents

Autor:innen und Institutionen

  • Center for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.
  • Department of Mathematics and Statistics, University of Montreal, Montreal, Quebec, Canada.
  • Division of Infectious Diseases, St. Michael's Hospital, Toronto, Canada.
  • Department of Medicine, University of Toronto, Toronto, Canada.
  • Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada.
  • Sorbonne Université, Inserm, Institut Pierre Louis d'Épidémiologie et de Santé Publique (iPLESP), Paris, France.

ORCID-Profile: Kim Engler, Darrell H S Tan

Förderung

  • Canadian HIV Trials Network, Canadian Institutes of Health Research
  • Strategy for Patient-Oriented Research
  • Merck Canada
  • MSDAVENIR

Zitieren

APA

Engler, K., Lessard, D., Vicente, S., Tan, D. H. S., Lacombe, K., & Lebouché, B. (2026). A multi-phase project to develop a patient-reported measure of barriers to antiretroviral therapy adherence for use in HIV care: The 7-Item I-Score. PLOS One, 21(1), e0324241. https://doi.org/10.1371/journal.pone.0324241

Vancouver

Engler K, Lessard D, Vicente S, Tan DHS, Lacombe K, Lebouché B. A multi-phase project to develop a patient-reported measure of barriers to antiretroviral therapy adherence for use in HIV care: The 7-Item I-Score. PLOS One. 2026;21(1):e0324241. doi:10.1371/journal.pone.0324241

BibTeX
@article{Engler2026,
  author = {Engler, Kim and Lessard, David and Vicente, Serge and Tan, Darrell H S and Lacombe, Karine and Lebouché, Bertrand},
  title = {A multi-phase project to develop a patient-reported measure of barriers to antiretroviral therapy adherence for use in HIV care: The 7-Item I-Score},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {1},
  pages = {e0324241},
  doi = {10.1371/journal.pone.0324241}
}
Kostenlos starten →